Department of Radiology, University of California, San Diego, San Diego, California.
Department of Pathology, University of California, San Diego, San Diego, California.
Cancer Res. 2014 Sep 1;74(17):4638-52. doi: 10.1158/0008-5472.CAN-13-3534.
Diffusion-weighted imaging (DWI) has been at the forefront of cancer imaging since the early 2000s. Before its application in clinical oncology, this powerful technique had already achieved widespread recognition due to its utility in the diagnosis of cerebral infarction. Following this initial success, the ability of DWI to detect inherent tissue contrast began to be exploited in the field of oncology. Although the initial oncologic applications for tumor detection and characterization, assessing treatment response, and predicting survival were primarily in the field of neurooncology, the scope of DWI has since broadened to include oncologic imaging of the prostate gland, breast, and liver. Despite its growing success and application, misconceptions about the underlying physical basis of the DWI signal exist among researchers and clinicians alike. In this review, we provide a detailed explanation of the biophysical basis of diffusion contrast, emphasizing the difference between hindered and restricted diffusion, and elucidating how diffusion parameters in tissue are derived from the measurements via the diffusion model. We describe one advanced DWI modeling technique, called restriction spectrum imaging (RSI). This technique offers a more direct in vivo measure of tumor cells, due to its ability to distinguish separable pools of water within tissue based on their intrinsic diffusion characteristics. Using RSI as an example, we then highlight the ability of advanced DWI techniques to address key clinical challenges in neurooncology, including improved tumor conspicuity, distinguishing actual response to therapy from pseudoresponse, and delineation of white matter tracts in regions of peritumoral edema. We also discuss how RSI, combined with new methods for correction of spatial distortions inherent in diffusion MRI scans, may enable more precise spatial targeting of lesions, with implications for radiation oncology and surgical planning. See all articles in this Cancer Research section, "Physics in Cancer Research."
弥散加权成像(DWI)自 21 世纪初以来一直处于癌症成像的前沿。在其在临床肿瘤学中的应用之前,由于在诊断脑梗死方面的实用性,这项强大的技术已经得到了广泛的认可。在最初的成功之后,DWI 检测固有组织对比的能力开始在肿瘤学领域得到利用。尽管最初的肿瘤学应用是在神经肿瘤学领域用于检测和表征肿瘤、评估治疗反应和预测生存,但 DWI 的范围已经扩大到包括前列腺、乳房和肝脏的肿瘤成像。尽管 DWI 取得了越来越多的成功和应用,但研究人员和临床医生对其潜在物理基础仍存在误解。在这篇综述中,我们详细解释了弥散对比的生物物理基础,强调了受限扩散和受阻扩散之间的区别,并阐明了如何从扩散模型的测量结果中得出组织中的扩散参数。我们描述了一种先进的 DWI 建模技术,称为限制谱成像(RSI)。由于能够根据组织内水的固有扩散特性区分可分离的水池,因此该技术为肿瘤细胞提供了更直接的体内测量。我们以 RSI 为例,强调了先进的 DWI 技术在神经肿瘤学中解决关键临床挑战的能力,包括提高肿瘤的显著性、区分实际治疗反应与假性反应以及描绘肿瘤周围水肿区的白质束。我们还讨论了 RSI 如何与固有于扩散 MRI 扫描的空间扭曲校正的新方法相结合,可能实现对病变更精确的空间靶向,对放射肿瘤学和手术规划具有重要意义。查看“癌症研究中的物理”这一癌症研究版块中的所有文章。